Latest Earnings Results: Q3 '26
Estimated EPS
-$0.12
Reported EPS
-$0.10
Surprise
+17.29%
Estimated Rev
$0.27M
Reported Rev
$0.21M
Surprise
-20.98%
• Reported GAAP EPS of -$0.10 up 41.18% YoY • Reported revenue of $0.21M down -61.82% YoY • Quantum-Si reiterated full-year 2026 revenue guidance of approximately $1M and lowered adjusted total operating expenses to $87M or less from $98M or less, and total cash usage to $87M or less from $93M or less.
Bullish Takeaway
Quantum-Si reported Proteus sequencing output approximately 30 times more per chamber in a controlled peptide study, advanced detection to 19 amino acids, launched pre-orders, and expects cash runway into Q4 2028.
Bearish Takeaway
Quantum-Si's Q3 revenue and gross profit were below prior-year levels, nine-month gross margin was 39% versus 52%, and AI-driven demand constrained component supply and extended lead times.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.11 | -- | -- | N/A |
Q3 '26 | -$0.12 | -$0.10 | 17.29% | BEAT |
Q2 '26 | -$0.11 | -$0.11 | 2.94% | BEAT |
Q1 '26 | -$0.11 | -$0.10 | 9.09% | BEAT |
Q4 '25 | -$0.12 | -$0.08 | 34.41% | BEAT |